Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CRDF

Cardiff Oncology (CRDF) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $1.08 +1.9% on the day -54.6% over 12 months 52-week range $0.81 – $3.21

Share price and insider trades

CRDF closeInsider buyInsider sale
01234NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $66,491 on 2026-06-18 · Gary W Pace, Mani MohindruBought $1,053,608 on 2026-07-14 · Gary W Pace, Mani Mohindru
Bought, 12 months$1.1M
Sold, 12 months$0
Insiders buying2
Insiders selling0

Cardiff Oncology insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $1.1M and 0 sold $0 of CRDF stock on the open market.

CRDF insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $66K bought (2 trades)$66KQ2 2026Q3 2026: $1.1M bought (2 trades)$1.1MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$1.1M2—0
Q2 2026$66K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit−$282KOn all tracked purchases -25.1%

Summary

Over the past 12 months, 2 Cardiff Oncology, Inc. insiders reported open-market purchases totaling $1.1M, while 0 insiders reported sales totaling $0.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 16SEC Gary W PaceDirector Buy 687,2852,043,661 held (+51%) $1.46 $1.0M -26.0% —
Jul 16SEC Mani MohindruCEO Buy 34,36459,067 held (+139%) $1.46 $50K -26.0% —
Jun 22SEC Gary W PaceDirector Buy 30,0001,356,376 held (+2%) $1.22 $37K -11.5% —
Jun 22SEC Mani MohindruCEO Buy 24,703new position $1.21 $30K -10.7% —

Insiders at Cardiff Oncology, Inc.

InsiderBoughtSoldLast filingScore
Gary W PaceDirector $1.0M — Jul 16, 2026 —
Mani MohindruCEO $80K — Jul 16, 2026 —

CRDF stock: common questions

Are Cardiff Oncology, Inc. insiders buying CRDF stock?

In the past 12 months, 2 insiders reported open-market purchases of CRDF worth $1.1M. The latest was Director Gary W Pace bought $1.0M of CRDF at $1.46 — largest purchase by this insider in our records; raises the stake by 51%.

Are Cardiff Oncology, Inc. insiders selling CRDF stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CRDF's 52-week range?

Over the past year CRDF has traded between $0.81 and $3.21. It last closed at $1.08 on Oct 9, 2026.